SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Panel Rejects Protein Sciences Corporation’s Cell Culture Flu Vaccine, Wants More Safety Data

November 20, 2009 | 
1 min read
Bookmark and Share

Reuters -- More safety data would be needed before a new type of influenza vaccine made in insect cells should get approval, federal advisers said on Thursday.
Regulatory
MORE ON THIS TOPIC
Glucagon-like peptide 1 (GLP1, 7-36) molecule The glucagon like peptide-1 receptor has a strong effect on the management of type 2 diabetes mellitus. 3d rendering
IN PARTNERSHIP WITH VIVA BIOTECH
Cyclic peptides open new drug frontiers, if manufacturing can keep up
September 14, 2026
 · 
6 min read
 · 
Jennifer C. Smith-Parker
Creative background as a blue abstract extreme perspective design element representing time travel or Psychedelic and hallucinogenic consciousness trip as a 3D illustration.
Psychedelics
Psychedelic therapies ride wave of public favor into FDA hearing
September 14, 2026
 · 
3 min read
 · 
Michael Gibney
Alarm clock with pause sign, take a break, menopause concept, hormone replacement therapy
FDA
Biohaven takes another hit as FDA pauses enrollment in pivotal trials for embattled epilepsy drug
September 10, 2026
 · 
3 min read
 · 
Heather McKenzie
Vector cartoon illustration of a business team standing at a crossroad with multiple arrows, discussing and choosing the right path toward success and future opportunities.
Drug pricing
Drugmakers cherry pick launch regions as MFN creates ‘policy environment like an earthquake’
September 10, 2026
 · 
4 min read
 · 
Annalee Armstrong